Possibilities
- High accuracy in differentiating between benign and malignant colorectal tumors
- Identification of patients (triage) who are highly likely to require subsequent diagnostic procedures, including invasive biopsy
Who is the test recommended for?
- Patients with suspected malignant colorectal tumors based on clinical-laboratory findings (changes in bowel habits: onset of diarrhea, constipation, or ribbon-like stools; presence of bright red or dark red blood in the stool with a tarry consistency; abdominal cramps, persistent pain or bloating; unexplained, rapid, and spontaneous weight loss; constant fatigue and malaise even after adequate rest; anemia related to chronic bleeding, fatigue, weakness, and pallor; elevated tumor markers CEA, CA19-9, CA 242) and/or imaging data (colonoscopy, ultrasound, MRI, etc.)
- Patients for whom a recent invasive biopsy was inconclusive or did not align with clinical observations
Diagnostic Characteristics
- The clinical sensitivity of the test is >99%, as demonstrated on samples from 1,147 patients with colorectal cancer
- The clinical specificity of the test is 98.70% and 95.47%, as determined by evaluating 700 cases with benign disease and 12,009 asymptomatic individuals
- The clinical sensitivity and specificity of the test for detecting circulating tumor DNA are 73.17% and 93.75%, respectively
Decided to take the test!
Decided to take the test!
Book your first consultation with a doctor
The doctor will inform you about the upcoming testing, answer any questions you may have, and then ask you to sign an informed consent form for the test. Then, the doctor will complete a special form (application) according to the requirements of Trublood
The doctor will inform you about the upcoming testing, answer any questions you may have, and then ask you to sign an informed consent form for the test. Then, the doctor will complete a special form (application) according to the requirements of Trublood
Prepare for the test
Collect Your Blood Sample:
- 10 days before blood draw: Avoid blood transfusions
- 24 hours before blood draw: Avoid CT/PET scans and surgical procedures
- 6 hours before blood draw: Do not eat (water is allowed)
Collect Your Blood Sample:
- No appointment needed at any ALFA Diagnostica (see locations below)
Book your second consultation with the doctor
The doctor will interpret your test results, answer any questions you have, and provide recommendations for your next steps
The doctor will interpret your test results, answer any questions you have, and provide recommendations for your next steps
Venous blood (30 ml), collected in 2 vacuum tubes with EDTA and 1 vacuum tube with STRECK, according to the Datar Cancer Genetics protocol
Transported by accredited carrier DHL in a specialized container at a temperature of +2°C to +6°C to the Datar Cancer Genetics laboratory in UK
Where can I get tested?
Chisinau
21 N. Теstemițanu, street
Monday – Tuesday, 07:30 - 14:30 I Wednesday, 07:30 - 09:00
Monday – Tuesday, 07:30 - 14:30 I Wednesday, 07:30 - 09:00
Laboratory Report
The test results provided in the laboratory report are intended for professional use only by qualified specialists, considering the capabilities/limitations/characteristics of the test, the patient's current health status, clinical history, and diagnostic data, and, if necessary, should be confirmed/excluded by standard medical procedures.
VIEW SAMPLE REPORTS IN ENGLISH
Book a medical consultation with an expert
Professional and attentive care for each patient
Rusnac Angela
Oncologist
Professional experience 32 years, the highest category
Professional experience 32 years, the highest category
Cost and terms
Cost, in MDL
Trublood Colorectal
36 000
Working days
15
Test Name
Do you have questions?
Call or send us a question
© 2024 Oncogene & ALFA Diagnostica. All rights reserved.
Designed by Targetolog.md.
Designed by Targetolog.md.